Form 4 for NVCR NovoCure Ltd
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-03 · accession 0001645113-22-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-11 | 2022-03-03 | NVCR | Cordova Ashley | CFO | M - OptEx | $14.61 | +5,040 | 64.7K | +8% | +$73.7K |
| DM | 2022-03-11 | 2022-03-03 | NVCR | Cordova Ashley | CFO | M - OptEx | $14.61 | -5,040 | 0 | -100% | -$73.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-03 | M | A | 1,200 | $11.46 | 65,888 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-03-03 | M | A | 3,840 | $15.60 | 64,688 | D | — | — | |
| 3 | Derivative | Options to Buy Ordinary Shares | 2022-03-03 | M | D | 1,200 | $11.46 | 7,736 | D | $11.46 · — to 2026-02-24 | 1,200 Ordinary Shares | (F1) Fully vested as of the date hereof. |
| 4 | Derivative | Options to Buy Ordinary Shares | 2022-03-03 | M | D | 3,840 | $15.60 | 0 | D | $15.60 · — to 2025-04-22 | 3,840 Ordinary Shares | (F1) Fully vested as of the date hereof. |